Shiv Shukla is a notable figure in the medical tech industry, known for his innovative and groundbreaking work as the Founder and CEO of NeuraLace Medical, Inc. With a focus on non-invasive therapeutic solutions, NeuraLace Medical offers a recurring revenue model and clinic-based solutions for a variety of medical conditions. Shukla has been instrumental in developing Axon Therapy at UCSD and VA, and has raised over $5.45 million in financing from an array of sources including angel investors, venture capitalists, and friends and family.

Shukla is a graduate of the University of California, Davis, where he earned a Bachelor of Science in Neurobiology, Physiology, and Behavior. Prior to NeuraLace Medical, Shukla held various roles in clinical research management at the Veterans Affairs Med Ctr and UC San Diego Health System.

Alongside his work at NeuraLace Medical, Shukla has served as a board member and advisor for Junto Global and as CEO and co-founder of Theraflux Medical, Inc. With a strong IP and a powerful board and team, Shukla is a respected leader in the medical tech space and a driving force behind many exciting innovations in non-invasive therapeutic solutions.